Singapore: Industrial production declines in December – UOB
|UOB Senior Economist Alvin Liew reports that Singapore's industrial production (IP) fell by 13.3% month-on-month in December 2025, aligning with market expectations. The decline was primarily driven by a significant drop in pharmaceuticals output, which decreased by 85.8%. Despite this, the overall IP showed an 8.3% year-on-year increase, with robust growth in other sectors like electronics and transport engineering.
December IP performance analysis
"Singapore’s industrial production (IP) recorded a back-to-back contraction in the last quarter of 2025, posting a -13.3% m/m sa decline in Dec (Nov revised: - 7.8%), in line with Bloomberg’s median forecast for a sequential pullback."
"On a m/m sa basis, the material drag in pharmaceuticals output for the second consecutive month in Dec was largely responsible for much of the year-end slowdown, coming in at -85.8% after -32.4% in Nov."
"That said, the contribution of electronics (on a y/y basis) remained very positive at 30.8% y/y in Dec, up from 18.1% in Nov, 26.9% in Oct, and the increase was led by the sub-category of semiconductors thanks to 'sustained and strong demand for AI-related products'."
"As for the remaining major segments of IP, transport engineering continued to provide support to overall manufacturing in Singapore (Dec: 19.9% y/y, Nov: 24.2% y/y) thanks to continued growth in both marine & offshore engineering (Dec: 8.5% y/y, Nov: 21.5%) and aerospace (Dec: 35.9% y/y, Nov: 33.8%)."
(This article was created with the help of an Artificial Intelligence tool and reviewed by an editor.)
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.